HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K I Pritchard Selected Research

MA 12 (MA12)

11/2013Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials.
2/2010A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K I Pritchard Research Topics

Disease

47Breast Neoplasms (Breast Cancer)
12/2020 - 01/2000
17Neoplasms (Cancer)
12/2020 - 03/2001
4Osteoporosis
02/2006 - 01/2001
3Cardiovascular Diseases (Cardiovascular Disease)
11/2011 - 01/2001
2Neoplasm Metastasis (Metastasis)
07/2018 - 10/2012
2Disease Progression
03/2011 - 06/2000
2Colonic Neoplasms (Colon Cancer)
03/2001 - 01/2001
2Hot Flashes
03/2001 - 01/2001
1Cardiotoxicity
12/2020
1Dementia (Dementias)
08/2019
1Hypoxia (Hypoxemia)
05/2014
1Hyperglycemia
04/2014
1Pneumonia (Pneumonitis)
04/2014
1Stomatitis
04/2014
1Bone Resorption
10/2012
1Proteinuria
03/2011
1Venous Thromboembolism
03/2011
1Hemorrhage
03/2011
1Hypertension (High Blood Pressure)
03/2011
1Colorectal Neoplasms (Colorectal Cancer)
02/2010
1Inflammatory Breast Neoplasms
09/2009
1Anemia
10/2007
1Fatigue
10/2007
1Arthralgia (Joint Pain)
02/2006
1Noninfiltrating Intraductal Carcinoma (DCIS)
07/2001
1Atrophy
03/2001
1Alzheimer Disease (Alzheimer's Disease)
03/2001

Drug/Important Bio-Agent (IBA)

12Hormones (Hormone)IBA
08/2019 - 01/2001
10TamoxifenFDA LinkGeneric
04/2018 - 01/2000
6AnthracyclinesIBA
12/2020 - 06/2000
6Aromatase InhibitorsIBA
04/2018 - 12/2001
6Letrozole (Femara)FDA LinkGeneric
11/2017 - 12/2001
5exemestane (Aromasin)FDA Link
12/2014 - 12/2001
4Diphosphonates (Bisphosphonates)IBA
10/2012 - 01/2001
4human ERBB2 proteinIBA
11/2011 - 09/2009
4Anastrozole (Arimidex)FDA LinkGeneric
02/2010 - 12/2001
3Proteins (Proteins, Gene)FDA Link
10/2018 - 07/2011
3Trastuzumab (Herceptin)FDA Link
07/2018 - 09/2009
3EverolimusFDA Link
12/2014 - 02/2013
3Epirubicin (Ellence)FDA LinkGeneric
05/2009 - 03/2003
3Fluorouracil (Carac)FDA LinkGeneric
05/2009 - 03/2003
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2009 - 03/2003
2MA 12 (MA12)IBA
11/2013 - 02/2010
2Zoledronic Acid (Zometa)FDA Link
10/2012 - 02/2006
2Type II DNA Topoisomerases (Topoisomerase II)IBA
07/2011 - 05/2009
2taxaneIBA
03/2011 - 01/2008
2Fulvestrant (Faslodex)FDA Link
06/2010 - 07/2003
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2007 - 03/2003
2Selective Estrogen Receptor Modulators (SERM)IBA
12/2001 - 03/2001
2Estrogens (Estrogen)FDA Link
03/2001 - 01/2001
2ProgesteroneFDA LinkGeneric
03/2001 - 01/2001
1Thyroid Hormone Receptors beta (TR beta)IBA
10/2018
1Alkaline PhosphataseIBA
07/2018
1palbociclibIBA
11/2017
1Epidermal Growth Factor (EGF)IBA
12/2014
1Formaldehyde (Formol)FDA Link
05/2014
1Biomarkers (Surrogate Marker)IBA
05/2014
1Phenobarbital (Luminal)FDA Link
05/2014
1ParaffinIBA
05/2014
1TOR Serine-Threonine KinasesIBA
04/2014
1CM 2-3IBA
11/2013
1Estrogen Receptor alphaIBA
08/2013
1Estrogen Receptor betaIBA
08/2013
1steroid receptor RNA activatorIBA
08/2013
1Bone Density Conservation AgentsIBA
10/2012
1Immunoglobulins (Immunoglobulin)IBA
10/2012
1LigandsIBA
10/2012
1DenosumabFDA Link
10/2012
1Pamidronate (Aredia)FDA LinkGeneric
10/2012
1Monoclonal AntibodiesIBA
10/2012
1diphosphoric acid (pyrophosphoric acid)IBA
10/2012
1Clodronic Acid (Clodronate)IBA
10/2012
1trioctyl phosphine oxide (TOPO)IBA
07/2011
1Bevacizumab (Avastin)FDA Link
03/2011
1ErbB Receptors (EGF Receptor)IBA
05/2009
1Methotrexate (Mexate)FDA LinkGeneric
05/2009
1FenretinideIBA
07/2006
1Paclitaxel (Taxol)FDA LinkGeneric
08/2005
1Docetaxel (Taxotere)FDA Link
08/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2003
1pyrachlostrobin (F 500)IBA
03/2003
1Filgrastim (Neupogen)FDA Link
03/2003
1Estrogen ReceptorsIBA
12/2001
1Estrogen Receptor Modulators (Antiestrogen)IBA
12/2001
1Raloxifene Hydrochloride (Evista)FDA Link
12/2001
1Antihypertensive Agents (Antihypertensives)IBA
03/2001
1LipidsIBA
03/2001
1CalciumIBA
03/2001

Therapy/Procedure

20Therapeutics
08/2019 - 04/2000
9Drug Therapy (Chemotherapy)
12/2020 - 08/2005
4Adjuvant Chemotherapy
07/2011 - 01/2008
3Aftercare (After-Treatment)
12/2014 - 05/2003
3Hormone Replacement Therapy (Therapy, Hormone Replacement)
05/2003 - 01/2001
2Radiotherapy
10/2018 - 05/2014
2Neoadjuvant Therapy
09/2009 - 03/2003
2Estrogen Replacement Therapy
03/2001 - 01/2001
1Segmental Mastectomy (Lumpectomy)
05/2014
1Combination Drug Therapy (Combination Chemotherapy)
01/2008
1Chemoprevention
12/2001
1Mastectomy (Mammectomy)
07/2001